The TB 500/BPC 157 blend by Peptide Hubs is formulated to support injury recovery, inflammation reduction, and connective tissue repair. This report presents verified lab results for the dual-peptide formula, confirming its content and manufacturing quality.
Test Overview
- Test Date: April 22, 2025
- Product: TB 500/BPC 157 10 mg
- Manufacturer: Peptide Hubs
- Labeled Dosage: 5 mg TB 500 + 5 mg BPC 157
- Tested Dosage: 5.40 mg TB 500 + 5.71 mg BPC 157
Results Summary
Independent lab analysis confirmed the product contains 5.40 mg of Thymosin Beta 4 (TB 500) and 5.71 mg of Pentadecapeptide (BPC 157). Both exceed the label claims, demonstrating strong quality control and consistency in production.
Further Reading
To learn more about real-world use cases, stacking strategies, and user feedback, read our full Peptide Hubs TB 500/BPC 157 review.
Conclusion
Peptide Hubs TB 500/BPC 157 10 mg delivers on its label and beyond. With both peptides tested above stated concentrations, this blend is a reliable choice for enhanced recovery and healing support.